TCL Archive In Brief: Clinical Education Program to Be Phased Out; Ken Endicott Retires From Grupenhoff Firm January 31, 1986
TCL Archive Abraxane Improves Progression-Free Survival Compared to Decarbazine In Stage IV Disease November 30, 2012
TCL Archive In Brief: Congress Sets NCI Rescission At $10.785 Million; Centers to Be Funded According To Priority Scores June 12, 1981